Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

PubWeight™: 5.39‹?› | Rank: Top 1%

🔗 View Article (PMID 16249550)

Published in Diabetes Care on November 01, 2005

Authors

Earl S Ford1

Author Affiliations

1: Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. eford@cdc.gov

Articles citing this

(truncated to the top 100)

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46

The metabolic syndrome. Endocr Rev (2008) 5.33

Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab (2010) 2.58

Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health (2007) 2.29

Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab (2009) 1.93

Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci U S A (2013) 1.89

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract (2008) 1.69

On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol (2008) 1.68

Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychol Med (2015) 1.55

Rodent models for metabolic syndrome research. J Biomed Biotechnol (2010) 1.53

Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol (2008) 1.51

Sexual differences in the control of energy homeostasis. Front Neuroendocrinol (2009) 1.50

Prevalence of the metabolic syndrome in San Juan, Puerto Rico. Ethn Dis (2008) 1.47

Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity (Silver Spring) (2013) 1.47

Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol (2008) 1.46

AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clin Sci (Lond) (2009) 1.43

Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol (2009) 1.40

Metabolic syndrome among Sri Lankan adults: prevalence, patterns and correlates. Diabetol Metab Syndr (2012) 1.39

Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med (2008) 1.38

Prevalence of Metabolic Syndrome among Working Adults in Ethiopia. Int J Hypertens (2011) 1.36

Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med (2009) 1.34

Fetal programming and metabolic syndrome. Annu Rev Physiol (2011) 1.31

Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ Health Perspect (2008) 1.28

The prevalence of metabolic syndrome and cardiovascular risk factors in adults in southern China. BMC Public Health (2012) 1.26

The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr (2009) 1.25

Empirical evidence for "syndrome Z": a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep (2009) 1.24

Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol (2007) 1.22

Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis (2010) 1.18

Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol (2013) 1.17

Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res (2010) 1.15

The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am (2009) 1.13

The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample. J Psychosom Res (2010) 1.13

Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes. Genes Immun (2011) 1.12

Does genetic variation in the Delta6-desaturase promoter modify the association between alpha-linolenic acid and the prevalence of metabolic syndrome? Am J Clin Nutr (2009) 1.12

The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. J Obes (2010) 1.11

Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study. BMC Public Health (2011) 1.11

Heritability of metabolic syndrome traits in a large population-based sample. J Lipid Res (2013) 1.10

Comprehensive assessment of metabolic syndrome among rural Bangladeshi women. BMC Public Health (2012) 1.07

Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care (2008) 1.06

Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc (2008) 1.06

Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord (2010) 1.04

Construct validity of a continuous metabolic syndrome score in children. Diabetol Metab Syndr (2010) 1.04

Prevalence and determinants of metabolic syndrome according to three definitions in middle-aged Chinese men. Metab Syndr Relat Disord (2009) 1.03

Defining genetic determinants of the Metabolic Syndrome in the Framingham Heart Study using association and structural equation modeling methods. BMC Proc (2009) 1.03

Dramatic escalation in metabolic syndrome and cardiovascular risk in a Chinese population experiencing rapid economic development. BMC Public Health (2014) 1.03

Prevalence of metabolic syndrome and gender differences. Bioinformation (2012) 1.02

Association between physical activity and metabolic syndrome: a cross sectional survey in adolescents in Ho Chi Minh City, Vietnam. BMC Public Health (2010) 1.02

Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J Diabetes Metab Disord (2013) 1.01

Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Ther (2008) 1.01

Individual and area-based indicators of acculturation and the metabolic syndrome among low-income Mexican American women living in a border region. Am J Public Health (2008) 1.01

Sociodemographic disparities in the composition of metabolic syndrome components among adults in South Korea. Diabetes Care (2012) 1.01

Prevalence of metabolic syndrome among urban community residents in China. BMC Public Health (2013) 1.00

Prevalence of the metabolic syndrome in a rural population in Ghana. BMC Endocr Disord (2012) 0.99

Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch Med Sci (2013) 0.99

Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Public Health (2007) 0.99

Cardiovascular disease risk reduction with sleep apnea treatment. Expert Rev Cardiovasc Ther (2010) 0.99

Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol (2012) 0.97

The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol (2013) 0.96

Resistant hypertension and obstructive sleep apnea in the primary-care setting. Int J Hypertens (2011) 0.95

Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men. Cardiovasc Diabetol (2007) 0.94

New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. Diabetol Metab Syndr (2011) 0.94

Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol Med (2011) 0.94

Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02. PLoS One (2012) 0.93

Obesity and cancer pathogenesis. Ann N Y Acad Sci (2014) 0.93

The links between insulin resistance, diabetes, and cancer. Curr Diab Rep (2013) 0.92

Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? J Womens Health (Larchmt) (2008) 0.92

Obstructive sleep apnea and cardiovascular disease: evidence and underlying mechanisms. Minerva Pneumol (2009) 0.92

Redefining the role of thiazolidinediones in the management of type 2 diabetes. Vasc Health Risk Manag (2009) 0.91

Insulin resistance: a new consequence of altered carotid body chemoreflex? J Physiol (2016) 0.91

Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome. Can J Cardiol (2010) 0.91

Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity. BMC Public Health (2011) 0.91

Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med (2016) 0.90

Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey. J Epidemiol Community Health (2007) 0.90

Research on intracranial atherosclerosis from the East and west: why are the results different? J Stroke (2014) 0.90

Guava leaf extracts promote glucose metabolism in SHRSP.Z-Leprfa/Izm rats by improving insulin resistance in skeletal muscle. BMC Complement Altern Med (2013) 0.90

Survey of abdominal obesities in an adult urban population of Kinshasa, Democratic Republic of Congo. Cardiovasc J Afr (2007) 0.90

Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am (2010) 0.90

Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial. Nutr Metab (Lond) (2008) 0.89

Energy expenditure is affected by rate of accumulation of sleep deficit in rats. Sleep (2010) 0.88

The prevalence and social patterning of chronic diseases among older people in a population undergoing health transition. A 10/66 Group cross-sectional population-based survey in the Dominican Republic. BMC Public Health (2010) 0.88

Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet? Arch Med Sci (2011) 0.88

Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res (2015) 0.88

A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U.S. population. Metab Syndr Relat Disord (2011) 0.87

The prevalence of metabolic syndrome and associated risk factors in Northern Plains and Southwest American Indians. Diabetes Care (2010) 0.87

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C--a cross-sectional study. Vasc Health Risk Manag (2014) 0.87

Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review. Am J Nephrol (2009) 0.87

Early change of extracellular matrix and diastolic parameters in metabolic syndrome. Arq Bras Cardiol (2013) 0.87

Fatalism and cardio-metabolic dysfunction in Mexican-American women. Int J Behav Med (2013) 0.87

Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study. PLoS One (2014) 0.87

Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep (2010) 0.87

A call to arms: obese men with more severe comorbid disease and underutilization of bariatric operations. Surg Endosc (2013) 0.87

Ocular associations of metabolic syndrome. Indian J Endocrinol Metab (2012) 0.86

Metabolic syndrome and changes in body fat from a low-fat diet and/or exercise randomized controlled trial. Obesity (Silver Spring) (2009) 0.86

Genetic effects on DNA methylation and its potential relevance for obesity in Mexican Americans. PLoS One (2013) 0.86

Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes. PLoS One (2013) 0.86

Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells. Proc Natl Acad Sci U S A (2014) 0.86

The metabolic syndrome and the immediate antihypertensive effects of aerobic exercise: a randomized control design. BMC Cardiovasc Disord (2008) 0.85

Excess body mass index loss predicts metabolic syndrome remission after gastric bypass. Diabetol Metab Syndr (2014) 0.85

Clinical Characteristics of Type 2 Diabetes Patients according to Family History of Diabetes. Korean Diabetes J (2010) 0.85

β-Cell dysfunction is associated with metabolic syndrome severity in adults. Metab Syndr Relat Disord (2013) 0.84

Articles by these authors

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care (2005) 7.05

Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care (2004) 6.68

Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch Intern Med (2009) 4.15

The epidemiology of obesity and asthma. J Allergy Clin Immunol (2005) 2.87

Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem (2004) 2.42

Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes (2010) 2.39

Dietary magnesium intake in a national sample of US adults. J Nutr (2003) 1.63

Social integration and concentrations of C-reactive protein among US adults. Ann Epidemiol (2005) 1.48

Adverse childhood experiences and smoking status in five states. Prev Med (2011) 1.17

Sedentary behavior, physical activity, and concentrations of insulin among US adults. Metabolism (2010) 1.11

Trends in low-risk lifestyle factors among adults in the United States: findings from the Behavioral Risk Factor Surveillance System 1996-2007. Prev Med (2010) 1.09

Combined television viewing and computer use and mortality from all-causes and diseases of the circulatory system among adults in the United States. BMC Public Health (2012) 0.94

Uric acid and mortality from all-causes and cardiovascular disease among adults with and without diagnosed diabetes: findings from the National Health and Nutrition Examination Survey III Linked Mortality Study. Diabetes Res Clin Pract (2011) 0.82

Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose. Atherosclerosis (2005) 0.80

Distribution of 7-year risk of diabetes mellitus among United States adults. Diabetes Res Clin Pract (2010) 0.75